IMDX Competitors & Alternatives
Compare Insight Molecular Diagnostics Inc. Common Stock with similar stocks in the same industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
IMDX
Main Stock$2.55
Tradestie Score
41
Market Cap
$94.16M
Revenue Growth
-0.2%
Analyst Upside
+226.8%
Top Competitors
19 stocks in IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IDXX
Idexx Laboratories Inc
|
$557.09
|
$49.61B | 42.8 | 59 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$73.09
|
$3.51B | 21.8 | 55 | Compare |
|
QDEL
QuidelOrtho Corporation Common Stock
|
$15.26
|
$2.12B | - | 51 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.65
|
$2.01B | - | 52 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$29.48
|
$1.68B | - | 46 | Compare |
|
NNNN
Anbio Biotechnology Class A Ordinary Shares
|
$24.61
|
$1.53B | 398.7 | 56 | Compare |
|
NEOG
Neogen Corp
|
$8.91
|
$1.26B | - | 52 | Compare |
|
MYGN
Myriad Genetics Inc
|
$4.36
|
$719.23M | - | 52 | Compare |
|
TKNO
Alpha Teknova, Inc. Common Stock
|
$2.68
|
$340.89M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$2.67
|
$158.43M | - | 48 | Compare |
More IMDX Analysis
Data updated: Mar 30, 2026 | Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES (SIC 2835)
19 stocks in this industry